Hims & Hers Health, Inc. (HIMS) Securities Fraud Class Action Lawsuit Filed; November 2, 2026, Lead Plaintiff Deadline
prnewswire·- Kessler Topaz Meltzer & Check, LLP announced that a securities fraud class action lawsuit has been filed against Hims & Hers Health, Inc. on behalf of investors who purchased securities between August 4, 2025 and July 29, 2026. - The lawsuit alleges that HIMS made false or misleading statements by failing to disclose deceptive privacy practices, including sharing consumer health information with third-party advertisers like Meta and Snap. - Affected investors have until November 2, 2026, to seek lead plaintiff status in the court proceedings following the 14.73% drop in HIMS stock price triggered by an FTC complaint.J.P. Morgan Assigns Hims & Hers Stock a 'Hold' Rating. What's Behind the Cautious Stance?
Tip Ranks·- JPMorgan initiated coverage of Hims & Hers Health with a Hold rating and a 32 USD price target. - The analyst cited potential growth from brand GLP-1 treatments, international expansion, and new specialty domains. - A cautious stance is maintained until there is clear execution on strategic transitions and sustainable margin expansion.Hims & Hers falls 3% in regular trading on FTC data sharing lawsuit
US Stock Market Update·Hims & Hers edges up in premarket amid class-action lawsuit over data sharing
US Stock Market Update·